FNCH

Finch Therapeutics Group, Inc. FNCH

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode FNCH IKNA HOWL EWTX QNRX KTTA CNTB BMEA
6M -1.61 % 2.88 % 129.58 % 32.31 % 281.75 % -47.23 % 197.60 % -4.00 %
YTD 7.96 % -13.33 % 4.49 % -44.10 % 2 952.87 % -74.42 % 53.72 % -54.47 %
1Y 4.72 % -22.70 % -16.84 % -52.51 % 3 919.61 % -84.16 % 32.86 % -83.86 %
3Y -75.20 % -70.33 % -60.63 % 41.35 % 0.49 % -97.00 % 92.75 % -82.05 %
5Y -98.09 % -95.53 % -89.88 % -49.63 % -98.45 % -98.95 % -89.94 % -90.12 %
10Y -98.09 % -95.53 % -89.88 % -49.63 % -99.87 % -98.95 % -89.94 % -90.12 %
From the beginning -98.09 % -95.53 % -89.88 % -49.63 % -99.87 % -98.95 % -89.94 % -90.12 %

Dividend